BioCentury
ARTICLE | Clinical News

Allervax Cat peptide immunotherapeutic: Began enrollment of 300 allergic patients in a Phase III trial

April 10, 1995 7:00 AM UTC

ImmuLogic Pharmaceutical Corp. (IMUL), Waltham, Mass. Product: Allervax Cat peptide immunotherapeutic Indication: Cat allergy Status: Began enrollment of 300 allergic patients in a Phase III trial ...